The effect of compound ma_ol_asal” syrup on oligomenorrhea in patients with polycystic ovary syndrome
Phase 2
Recruiting
- Conditions
- Oligomenorrhoea.Secondary OligomenorrhoeaN91.4
- Registration Number
- IRCT20200112046087N5
- Lead Sponsor
- Traditional Medicine and Materia Medica Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
All women with PCO who present with an oligomenorrhea complaint and consent to the study
Exclusion Criteria
People with any type of systemic disease such as diabetes, Cushing's, adrenal hyperplasia, hyperprolactin, hyper thyroidism
Pregnant women and women who are breastfeeding (the first 6 months) are either planning to become pregnant or women who have had an abortion
People taking hormonal medications, including LD pills
People with a history of breast and ovarian cancer and people undergoing chemotherapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect of ma_ol_asal”syrup on the duration of bleeding in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient.;The effect of ma_ol_asal” syrup on bleeding rate in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Pictorial Bleeding Assessment Chart (PBAC).;The effect of ma_ol_asal” syrup on BMI in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Meters and scales and BMI formula.
- Secondary Outcome Measures
Name Time Method Menstrual period. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient.;Cleanliness period. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient.